IDEAYA Biosciences IDYA

$ 25.68 3.01%

Quarterly report 2024-Q3
added 11-04-2024

IDEAYA Biosciences Balance Sheet 2011-2025 | IDYA

Annual Balance Sheet IDEAYA Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-154 M	-65.2 M	-86.9 M	-	-27.3 M	-20.5 M	-5.96 M	-	-	-	-	-	-
Long Term Debt	1.12 M	1.61 M	3.48 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.75 M	1.87 M	1.7 M	1.54 M	1.14 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	5.66 M	140 M	30.8 M	-	-	-	-	-	-
Total Current Liabilities	27.1 M	31.7 M	45.2 M	38.6 M	6.94 M	-	-	-	-	-	-	-	-
Total Liabilities	28.2 M	38.5 M	79.8 M	100 M	12.6 M	145 M	33.2 M	-	-	-	-	-	-
Deferred Revenue	-	8.57 M	29 M	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-348 M	-235 M	-177 M	-	-92.5 M	-50.5 M	-16.2 M	-	-	-	-	-	-
Total Assets	649 M	388 M	381 M	298 M	113 M	96.5 M	17.5 M	-	-	-	-	-	-
Cash and Cash Equivalents	157 M	68.6 M	92 M	72 M	34.1 M	20.5 M	6.03 M	-	-	-	-	-	-
Book Value	621 M	349 M	302 M	198 M	100 M	-48.9 M	-15.7 M	-	-	-	-	-	-
Total Shareholders Equity	621 M	349 M	302 M	198 M	100 M	-48.9 M	-15.7 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet IDEAYA Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	18.8 M	1.26 M	1.26 M	1.12 M	-	611 K	1.12 M	1.61 M	2.1 M	2.57 M	3.03 M	3.48 M	3.92 M	4.36 M	4.77 M	5.18 M	5.18 M	5.18 M	5.18 M	5.63 M	5.63 M	5.63 M	5.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	59.5 M	42 M	26.2 M	28.2 M	24.9 M	25.9 M	30.9 M	38.5 M	42.1 M	68.7 M	70.2 M	79.8 M	81.8 M	88.1 M	93 M	100 M	100 M	100 M	100 M	12.6 M	12.6 M	12.6 M	12.6 M	7.1 M	7.1 M	7.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	1.44 M	2.82 M	6.26 M	8.57 M	10.3 M	35.8 M	39.2 M	29 M	22.9 M	22.1 M	25.5 M	27.6 M	27.6 M	27.6 M	27.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-493 M	-441 M	-388 M	-348 M	-314 M	-287 M	-259 M	-235 M	-211 M	-213 M	-191 M	-177 M	-159 M	-147 M	-136 M	-127 M	-127 M	-127 M	-127 M	-92.5 M	-92.5 M	-92.5 M	-92.5 M	-50.5 M	-50.5 M	-50.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1.24 B	974 M	962 M	649 M	533 M	528 M	365 M	388 M	411 M	338 M	359 M	381 M	399 M	328 M	326 M	298 M	298 M	298 M	298 M	113 M	113 M	113 M	113 M	96.5 M	96.5 M	96.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	400 M	183 M	108 M	157 M	152 M	103 M	67.2 M	68.6 M	102 M	49.1 M	55.3 M	92 M	108 M	90.4 M	137 M	72 M	72 M	72 M	72 M	34.1 M	34.1 M	34.1 M	34.1 M	20.5 M	20.5 M	20.5 M	-	5.96 M	-	-	-	9.69 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	1.18 B	932 M	935 M	621 M	508 M	502 M	334 M	349 M	369 M	269 M	289 M	302 M	318 M	240 M	233 M	198 M	198 M	198 M	198 M	100 M	100 M	100 M	100 M	89.4 M	89.4 M	89.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	1.18 B	932 M	935 M	621 M	508 M	502 M	334 M	349 M	369 M	269 M	289 M	302 M	318 M	240 M	233 M	198 M	198 M	198 M	198 M	100 M	100 M	100 M	100 M	-48.9 M	-48.9 M	-48.9 M	-21.3 M	-15.7 M	-	-	-	-4.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency